The aim of our retrospective observational study was to verify, in a real-life setting, whether pentameric IgM-enriched immunoglobulin may improve clinical outcome and survival when early associated with antibiotic treatment in patients with sepsis admitted to an intensive care unit (ICU). This evidence concerns the gene CD40LG and Sepsis.